Treatment of Pedophilia with Leuprolide Acetate: A Case Study (From Sex Offender Treatment: Accomplishments, Challenges, and Future Directions, P 79-88, 2001, Eli Coleman and Michael H. Miner, eds. -- See NCJ-199818)

• NCJ Number: 199823
• Author(s): Nancy Raymond M.D.; Bean Robinson Ph.D.; Chris Kraft Ph.D.; Barry Rittberg M.D.; Eli Coleman Ph.D.
• Date Published: 2001
• Length: 10 pages
• Sale Source: Haworth Press, Inc
• Publication Format: Book (Softbound)
• Publication Type: Report (Study/Research)
• Language: English
• Country: United States of America

Annotation

This paper reports on a case study on the effectiveness of the use of leuprolide acetate in the treatment of sex offenders, specifically pedophilia.

Abstract

To date, the literature on the treatment of individuals who have committed sexual offenses have focused primarily on psychotherapeutic interventions and the use of antiandrogens. This paper presents a case study of a 41-year old male who presented voluntarily for treatment in the sex offender treatment program and illustrates a challenging instance of an individual with pedophilia and numerous comorbid diagnoses requiring the use of pharmacotherapy in combination with specialized psychological sex offender treatment. Even though mono-pharmacotherapy may be effective as a first line response in the treatment of sexual offenders, this case report illustrates that leuprolide acetate can be effective in decreasing pedophilic fantasies, urges, and behaviors. In addition, individuals who receive effective individualized pharmacotherapeutic treatment for compulsive sexual urges and comorbid psychiatric conditions also respond better to psychotherapeutic interventions. References